Literature DB >> 18324398

Nephrogenic systemic fibrosis: chronic imaging findings and review of the medical literature.

Jeffrey P Weigle1, Dale R Broome.   

Abstract

Nephrogenic systemic fibrosis (NSF) is a systemic fibrosing disorder which has been strongly associated with exposure to gadolinium-based contrast media (GBCM) in the setting of renal insufficiency. Although this disorder primarily affects the skin, it can result in severe joint contractures, disabilities and even death. However, to date, there have been no published studies reporting chronic imaging findings of NSF. In this report we present three biopsy-proven cases of NSF with the associated chronic MRI, radiographic and bone scintigraphy findings. Two of the patients had been exposed to gadodiamide, and one had been exposed to gadopentetate dimeglumine prior to the onset of NSF. Two are newly reported cases. One patient's subacute imaging findings have previously been reported, but significant chronic images will now be presented. This patient became severely disabled from contractures and developed long bone smooth periosteal reaction, extensive intra-articular and periarticular calcifications, musculotendinous heterotopic ossification and ankylosis of several joints. One of the patients underwent renal transplantation 6 months after GBCM exposure, with near complete resolution of the skin fibrosis. The third patient had persistent MRI findings of skin thickening, with low T1 and high T2 signal intensity 5 years after exposure to gadodiamide. A review of the medical literature is provided, emphasizing the association of NSF with various GBCM. These cases broaden our understanding of the long-term imaging findings and complications of NSF and the stratified risk of NSF with various GBCM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18324398     DOI: 10.1007/s00256-008-0464-1

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  54 in total

Review 1.  Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: report of a new case with literature review.

Authors:  Sumanth R Daram; Cherise M Cortese; Bahar Bastani
Journal:  Am J Kidney Dis       Date:  2005-10       Impact factor: 8.860

2.  Nephrogenic systemic fibrosis among liver transplant recipients: a single institution experience and topic update.

Authors:  M Maloo; P Abt; R Kashyap; D Younan; M Zand; M Orloff; A Jain; A Pentland; G Scott; A Bozorgzadeh
Journal:  Am J Transplant       Date:  2006-06-19       Impact factor: 8.086

3.  Long-term retention of gadolinium in tissues from nephrogenic systemic fibrosis patient after multiple gadolinium-enhanced MRI scans: case report and implications.

Authors:  Charu Thakral; Jihad Alhariri; Jerrold L Abraham
Journal:  Contrast Media Mol Imaging       Date:  2007-07       Impact factor: 3.161

4.  Traumatic calcinosis cutis in a dialysis patient.

Authors:  Eric N Taylor; Joel M Henderson; Helmut G Rennke; Colm C Magee
Journal:  Am J Kidney Dis       Date:  2004-08       Impact factor: 8.860

Review 5.  Circulating fibrocytes: collagen-secreting cells of the peripheral blood.

Authors:  Timothy E Quan; Shawn Cowper; Sou-Pan Wu; Linda K Bockenstedt; Richard Bucala
Journal:  Int J Biochem Cell Biol       Date:  2004-04       Impact factor: 5.085

6.  Nephrogenic systemic fibrosis: relationship to gadolinium and response to photopheresis.

Authors:  Heather Richmond; Jeffrey Zwerner; Youn Kim; David Fiorentino
Journal:  Arch Dermatol       Date:  2007-08

7.  Nephrogenic systemic fibrosis: a population study examining the relationship of disease development to gadolinium exposure.

Authors:  Aneet Deo; Mitchell Fogel; Shawn E Cowper
Journal:  Clin J Am Soc Nephrol       Date:  2007-02-07       Impact factor: 8.237

8.  Nephrogenic systemic fibrosis: a mysterious disease in patients with renal failure--role of gadolinium-based contrast media in causation and the beneficial effect of intravenous sodium thiosulfate.

Authors:  Preethi Yerram; Georges Saab; Poorna R Karuparthi; Melvin R Hayden; Ramesh Khanna
Journal:  Clin J Am Soc Nephrol       Date:  2007-02-07       Impact factor: 8.237

9.  Calciphylaxis and metastatic calcification associated with nephrogenic fibrosing dermopathy.

Authors:  Lisa C Edsall; Joseph C English; Mark W Teague; James W Patterson
Journal:  J Cutan Pathol       Date:  2004-03       Impact factor: 1.587

10.  A variant of nephrogenic fibrosing dermopathy with osteoclast-like giant cells: a syndrome of dysregulated matrix remodeling?

Authors:  Klilah Hershko; Cheryl Hull; Leila Ettefagh; Susan Nedorost; Senait Dyson; Thomas Horn; Anita C Gilliam
Journal:  J Cutan Pathol       Date:  2004-03       Impact factor: 1.587

View more
  6 in total

1.  Metallofullerene-based nanoplatform for brain tumor brachytherapy and longitudinal imaging in a murine orthotopic xenograft model.

Authors:  Michael D Shultz; John D Wilson; Christine E Fuller; Jianyuan Zhang; Harry C Dorn; Panos P Fatouros
Journal:  Radiology       Date:  2011-08-03       Impact factor: 11.105

Review 2.  Nephrogenic systemic fibrosis in liver disease: a systematic review.

Authors:  Sameer M Mazhar; Masoud Shiehmorteza; Chad A Kohl; Michael S Middleton; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2009-12       Impact factor: 4.813

3.  Editor's Highlight: In Utero Exposure to Gadolinium and Adverse Neonatal Outcomes in Premature Infants.

Authors:  Radhika Amin; Thomas Darrah; Hongyue Wang; Sanjiv Amin
Journal:  Toxicol Sci       Date:  2017-04-01       Impact factor: 4.849

4.  Gadolinium contrast agent-induced CD163+ ferroportin+ osteogenic cells in nephrogenic systemic fibrosis.

Authors:  Sundararaman Swaminathan; Chhanda Bose; Sudhir V Shah; Kimberly A Hall; Kim M Hiatt
Journal:  Am J Pathol       Date:  2013-07-16       Impact factor: 4.307

Review 5.  Gadolinium: pharmacokinetics and toxicity in humans and laboratory animals following contrast agent administration.

Authors:  Julie Davies; Petra Siebenhandl-Wolff; Francois Tranquart; Paul Jones; Paul Evans
Journal:  Arch Toxicol       Date:  2022-01-08       Impact factor: 5.153

Review 6.  Nephrogenic Systemic Fibrosis as a Complication after Gadolinium-Containing Contrast Agents: A Rapid Review.

Authors:  Sandra Lange; Wioletta Mędrzycka-Dąbrowska; Katarzyna Zorena; Sebastian Dąbrowski; Daniel Ślęzak; Anna Malecka-Dubiela; Przemysław Rutkowski
Journal:  Int J Environ Res Public Health       Date:  2021-03-15       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.